Inspire Medical Systems Inc
NYSE:INSP

Watchlist Manager
Inspire Medical Systems Inc Logo
Inspire Medical Systems Inc
NYSE:INSP
Watchlist
Price: 180.6348 USD -3.8%
Market Cap: 5.4B USD
Have any thoughts about
Inspire Medical Systems Inc?
Write Note

Net Margin
Inspire Medical Systems Inc

4.4%
Current
-9%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
4.4%
=
Net Income
33m
/
Revenue
755.6m

Net Margin Across Competitors

Country US
Market Cap 5.4B USD
Net Margin
4%
Country US
Market Cap 35.9B USD
Net Margin
25%
Country US
Market Cap 31.3B USD
Net Margin
10%
Country AU
Market Cap 26.7B AUD
Net Margin
50%
Country US
Market Cap 10.7B USD
Net Margin
34%
Country US
Market Cap 6.3B USD
Net Margin
-6%
Country JP
Market Cap 934B JPY
Net Margin
16%
Country SE
Market Cap 53.5B SEK
Net Margin
25%
Country US
Market Cap 2.4B EUR
Net Margin
-4%
Country CN
Market Cap 16.2B CNY
Net Margin
11%
Country US
Market Cap 2.1B USD
Net Margin
-2%
No Stocks Found

Inspire Medical Systems Inc
Glance View

Market Cap
5.4B USD
Industry
Health Care

Inspire Medical Systems Inc. emerged as a beacon of innovation in the medical technology landscape, carving a niche within the realm of obstructive sleep apnea (OSA) treatment. Founded with a vision to redefine the approach to sleep disorders, the company developed a breakthrough solution—a device that stimulates the hypoglossal nerve to maintain an open airway during sleep. This technology, known as Inspire therapy, represents a significant departure from traditional treatments like the cumbersome and often uncomfortable Continuous Positive Airway Pressure (CPAP) machines. By addressing the root cause of airway obstruction, Inspire provides an effective, less intrusive alternative, enhancing the overall quality of life for patients who struggle with conventional methods. Inspire Medical Systems makes money by marketing its implantable device primarily through a network of sleep centers and hospitals. The company operates in a business model that combines device sales with a supportive service infrastructure, ensuring that both healthcare providers and patients are well-acquainted with its innovative therapy. The revenue stream is fueled not only by the initial sales of the device but also through ongoing follow-ups and software updates necessary for optimal device functionality. By positioning itself at the intersection of customer care and cutting-edge technology, Inspire captures significant value in the growing OSA market, all while reinforcing its reputation as a leader in innovative medical solutions.

INSP Intrinsic Value
83.5049 USD
Overvaluation 54%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
4.4%
=
Net Income
33m
/
Revenue
755.6m
What is the Net Margin of Inspire Medical Systems Inc?

Based on Inspire Medical Systems Inc's most recent financial statements, the company has Net Margin of 4.4%.